Works matching IS 00070920 AND DT 2012 AND VI 106 AND IP 12

Results: 24

The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.

Published in:

2012

By:

Richards CH;
Flegg KM;
Roxburgh CS;
Going JJ;
Mohammed Z;
Horgan PG;
McMillan DC;
Richards, C H;
Flegg, K M;
Roxburgh, C S D;
Going, J J;
Mohammed, Z;
Horgan, P G;
McMillan, D C

Publication type:

journal article

γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer.

Published in:

2012

By:

Mizugaki H;
Sakakibara-Konishi J;
Ikezawa Y;
Kikuchi J;
Kikuchi E;
Oizumi S;
Dang TP;
Nishimura M;
Mizugaki, H;
Sakakibara-Konishi, J;
Ikezawa, Y;
Kikuchi, J;
Kikuchi, E;
Oizumi, S;
Dang, T P;
Nishimura, M

Publication type:

journal article

c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Published in:

2012

By:

Tudor CS;
Dawson CW;
Eckhardt J;
Niedobitek G;
Büttner AC;
Seliger B;
Hartmann A;
Buettner M;
Tudor, C S;
Dawson, C W;
Eckhardt, J;
Niedobitek, G;
Büttner, A C;
Seliger, B;
Hartmann, A;
Buettner, M

Publication type:

journal article

A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression.

Published in:

2012

By:

Oikawa K;
Tanaka M;
Itoh S;
Takanashi M;
Ozaki T;
Muragaki Y;
Kuroda M;
Oikawa, K;
Tanaka, M;
Itoh, S;
Takanashi, M;
Ozaki, T;
Muragaki, Y;
Kuroda, M

Publication type:

journal article

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.

Published in:

2012

By:

Androulakis N;
Agelaki S;
Perraki M;
Apostolaki S;
Bozionelou V;
Pallis A;
Kalbakis K;
Xyrafas A;
Mavroudis D;
Georgoulias V;
Androulakis, N;
Agelaki, S;
Perraki, M;
Apostolaki, S;
Bozionelou, V;
Pallis, A;
Kalbakis, K;
Xyrafas, A;
Mavroudis, D;
Georgoulias, V

Publication type:

journal article

The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1940, doi. 10.1038/bjc.2012.190

By:

Stapley, S;
Peters, T J;
Neal, R D;
Rose, P W;
Walter, F M;
Hamilton, W

Publication type:

Article

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1945, doi. 10.1038/bjc.2012.209

By:

Kususda, Y;
Miyake, H;
Gleave, M E;
Fujisawa, M

Publication type:

Article

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1997, doi. 10.1038/bjc.2012.145

By:

Hagiwara, S;
Kudo, M;
Nagai, T;
Inoue, T;
Ueshima, K;
Nishida, N;
Watanabe, T;
Sakurai, T

Publication type:

Article

A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1976, doi. 10.1038/bjc.2012.199

By:

Oikawa, K;
Tanaka, M;
Itoh, S;
Takanashi, M;
Ozaki, T;
Muragaki, Y;
Kuroda, M

Publication type:

Article

γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1953, doi. 10.1038/bjc.2012.178

By:

Mizugaki, H;
Sakakibara-Konishi, J;
Ikezawa, Y;
Kikuchi, J;
Kikuchi, E;
Oizumi, S;
Dang, T P;
Nishimura, M

Publication type:

Article

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1926, doi. 10.1038/bjc.2012.184

By:

De Bruyne, S;
Van Damme, N;
Smeets, P;
Ferdinande, L;
Ceelen, W;
Mertens, J;
Van de Wiele, C;
Troisi, R;
Libbrecht, L;
Laurent, S;
Geboes, K;
Peeters, M

Publication type:

Article

False-negative MRI biomarkers of tumour response to targeted cancer therapeutics.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1960, doi. 10.1038/bjc.2012.208

By:

Boult, J K R;
Jamin, Y;
Jacobs, V;
Gilmour, L D;
Walker-Samuel, S;
Halliday, J;
Elvin, P;
Ryan, A J;
Waterton, J C;
Robinson, S P

Publication type:

Article

The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 2010, doi. 10.1038/bjc.2012.211

By:

Richards, C H;
Flegg, K M;
SD Roxburgh, C;
Going, J J;
Mohammed, Z;
Horgan, P G;
McMillan, D C

Publication type:

Article

c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1980, doi. 10.1038/bjc.2012.197

By:

Tudor, C S;
Dawson, C W;
Eckhardt, J;
Niedobitek, G;
Büttner, A C;
Seliger, B;
Hartmann, A;
Buettner, M

Publication type:

Article

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1934, doi. 10.1038/bjc.2012.183

By:

Nakai, Y;
Isayama, H;
Sasaki, T;
Sasahira, N;
Tsujino, T;
Toda, N;
Kogure, H;
Matsubara, S;
Ito, Y;
Togawa, O;
Arizumi, T;
Hirano, K;
Tada, M;
Omata, M;
Koike, K

Publication type:

Article

The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1901, doi. 10.1038/bjc.2012.201

By:

Houthuijzen, J M;
Daenen, L G M;
Roodhart, J M L;
Voest, E E

Publication type:

Article

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1917, doi. 10.1038/bjc.2012.202

By:

Androulakis, N;
Agelaki, S;
Perraki, M;
Apostolaki, S;
Bozionelou, V;
Pallis, A;
Kalbakis, K;
Xyrafas, A;
Mavroudis, D;
Georgoulias, V

Publication type:

Article

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 2016, doi. 10.1038/bjc.2012.160

By:

Jakubowska, A;
Rozkrut, D;
Antoniou, A;
Hamann, U;
Scott, R J;
McGuffog, L;
Healy, S;
Sinilnikova, O M;
Rennert, G;
Lejbkowicz, F;
Flugelman, A;
Andrulis, I L;
Glendon, G;
Ozcelik, H;
Thomassen, M;
Paligo, M;
Aretini, P;
Kantala, J;
Aroer, B;
von Wachenfeldt, A

Publication type:

Article

FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1989, doi. 10.1038/bjc.2012.196

By:

Cimino, Y;
Costes, A;
Damotte, D;
Validire, P;
Mistou, S;
Cagnard, N;
Alifano, M;
Régnard, J-F;
Chiocchia, G;
Sautès-Fridman, C;
Tourneur, L

Publication type:

Article

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 2004, doi. 10.1038/bjc.2012.200

By:

Felix, A S;
Edwards, R P;
Stone, R A;
Chivukula, M;
Parwani, A V;
Bowser, R;
Linkov, F;
Weissfeld, J L

Publication type:

Article

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1967, doi. 10.1038/bjc.2012.207

By:

Bicaku, E;
Xiong, Y;
Marchion, D C;
Chon, H S;
Stickles, X B;
Chen, N;
Judson, P L;
Hakam, A;
Gonzalez-Bosquet, J;
Wenham, R M;
Apte, S M;
Fulp, W;
Cubitt, C L;
Chen, D-T;
Lancaster, J M

Publication type:

Article

Do the British public recognise differences in survival between three common cancers?

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1907, doi. 10.1038/bjc.2012.185

By:

Whitaker, K L;
Simon, A E;
Beeken, R J;
Wardle, J

Publication type:

Article

Referee Acknowledgement for 2011.

Published in:: British Journal of Cancer, 2012, v. 106, n. 12, p. 2039, doi. 10.1038/bjc.2012.249
Publication type:: Article

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.

Published in:

British Journal of Cancer, 2012, v. 106, n. 12, p. 1910, doi. 10.1038/bjc.2012.155

By:

Fourkala, E O;
Gentry-Maharaj, A;
Burnell, M;
Ryan, A;
Manchanda, R;
Dawnay, A;
Jacobs, I;
Widschwendter, M;
Menon, U

Publication type:

Article